
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Oroxylum Indicum Bark Extract
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Recipient : SF Research Institute, Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
Sabroxy Supplementation for Insulin Resistance and Cognition
Details : Oroxylum Indicum Bark Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Insulin Resistance.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
October 24, 2025
Lead Product(s) : Oroxylum Indicum Bark Extract
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Recipient : SF Research Institute, Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
